EDUCATION

Dr. Mahlaoui trained as a medical doctor at Claude Bernard Medical School (Lyon, France) and Bichat Medical School (Paris). He specialized in pediatric rheumatology, immunology and haematology at Necker Medical School (Paris) and is presently completing his PhD in Public Health-Epidemiology-Clinical Research at Paris Descartes University (Paris).

EXPERIENCE

Dr. Mahlaoui coordinates the French National Reference Center for Primary Immune Deficiencies (CEREDIH, www.ceredih.fr) at Necker-Enfants Malades University Hospital (Paris). He is chairman-elect of the European Society for Immunodeficiences (ESID) registry working party, Chairman  of  the  IPOPI (International Patient Organisation for PIDs) medical advisory panel and President of the French Paediatric Immuno-Hematology Society.

AREAS OF INTEREST

Dr. Mahlaoui focuses on PID and Severe combined immunodeficiency (SCID) screening, and haematopoietic  stem  cell  transplantation  or  gene therapy treatments. Dr. Mahlaoui advocates in favour of promoting PID and SCID newborn screening across the EU, through sharing best practices on diagnosis, research and developing clinical guidelines.

RESEARCH OVERVIEW

Recent studies have focused on characterizing immunodeficiency disease course, identifying outcome predictors and evaluating treatment responses, evaluating burden of disease in children with severe chronic conditions and PIDs, and the implications of transitioning from paediatric to adult medicine for patient management.